iTeos Therapeutics, Inc. (ITOS) Tops Q3 EPS by 26c

iTeos Therapeutics, Inc. (NASDAQ: ITOS) reported Q3 EPS of ($0.90), $0.26 better than the analyst estimate of ($1.16).

For earnings history and earnings-related data on iTeos Therapeutics, Inc. (ITOS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery